We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VRPX market cap is 447.48k. The company's latest EPS is USD -9.4384 and P/E is -0.04.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.68M | -3.3M | -3.46M | -1.92M | -3.4M |
| Net Income | -4.56M | -3.22M | -3.45M | -2.01M | -3.39M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.2M | -12.03M | -21.85M | -15.69M | -12.08M |
| Net Income | -4.34M | -12.06M | -21.65M | -15.19M | -12.07M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.63M | 3.13M | 2.59M | 304k | 1.56M |
| Total Liabilities | 7.69M | 4.34M | 5.39M | 2.36M | 2.47M |
| Total Equity | 1.93M | -1.21M | -2.79M | -2.05M | -914k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 465k | 39.57M | 19.67M | 9.63M | 1.56M |
| Total Liabilities | 4.68M | 2.09M | 3.1M | 7.69M | 2.47M |
| Total Equity | -4.22M | 37.49M | 16.58M | 1.93M | -914k |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.85M | -7.73M | -9.37M | -13.84M | -16.71M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 453k | 2.1M | 4.72M | 9.08M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.39M | -14.54M | -17.85M | -9.85M | -16.71M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.4M | 54.35M | N/A | N/A | 9.08M |
| Market Cap | 447.48k |
| Price to Earnings Ratio | -0.04 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.3 |
| Price to Book Ratio | -0.49 |
| Dividend Yield | - |
| Shares Outstanding | 1.28M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 246.26k |
| 52 Week Change | -87.50% |
| 52 Week High | 3.77 |
| 52 Week Low | 0.095 |
| Spread (Intraday) | 0.41 (62.12%) |
| Company Name | Virpax Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.virpaxpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
